The usoro na ntuziaka maka ojiji "Loraksona". Analogs na reviews

Gịnị bụ ndị dị otú ahụ a ọgwụ dị ka "Lorakson 500"? Ntuziaka maka ojiji, àgwà nke ngwá ọrụ, nakwa dị ka na-egosi, udi, mejupụtara na analogs na-atụle n'isiokwu n'okpuru.

Packaging, udi, mejupụtara nke ọgwụ

Gịnị udi bụ ihe e ji mara maka ewere ọgwụ? Gịnị ụgwọ a na-ekwu, ntụziaka ntuziaka? "Lorakson" bụ a crystalline ntụ ntụ nke na-acha ọcha ma ọ bụ ubé acha, bu n'obi maka nkwadebe nke igba ogwu n'akwara ma ọ bụ intramuscular ngwọta. The mejupụtara nke agwọ ọrịa na-agụnye nọ n'ọrụ mgwa dị ka ceftriaxone. Ọ na-dị n'ụdị ya sodium nnu.

Ọzọkwa, ọgwụ "Lorakson" ntụziaka ntuziaka nke a na-dị na a tojupụtara nke kaadiboodu na-agụnye a mgbaze dị ka mmiri ogwu ogbugba.

Isiokwu nkwadebe na-emepụta na iko vials nke 10 ml nke na-enịm ke akwụkwọ igbe (ga-ere ere na ma ọ bụ enweghị a mgbaze).

Pharmaceuticals Pharmaceutical Products

Gịnị bụ hotara na mbụ ọgwụ? Gịnị ọmụma nwere ntuziaka maka ojiji? "Lorakson" - ọgwụ nje (cephalosporin) ọgbọ nke atọ, bu n'obi maka parenteral ochichi. Ọ nwere bactericidal edinam.

Na ike na-inhibit njikọ nke cell membranes nke ọgwụ na-egbochi uto nke kasị gram-adịghị mma na gram-mma microorganisms.

Dị ka ndị ọkachamara, ceftriaxone egosi akpan akpan kwụsie ike megide beta-lactamase (penicillinase, cephalosporinase), nke na-emepụta ọtụtụ bacteria.

Kinetics ọgwụ

Olee otú emeso ngwaahịa na-agbasa na ahụ mmadụ? Gịnị a na-ekwu, ịdọkapụta ntuziaka maka ojiji? "Lorakson" on parenteral ochichi bụ ọma n'ime ihe fọrọ nke nta niile anụ ahụ na mmiri ahụ.

Na igba ogwu n'akwara infusion nke ceftriaxone mara mma ngwa ngwa diffuses n'ime interstitial ọmụmụ, ebe ya antibacterial Njirimara na-nọgidere na-enwe ihe n'ụbọchị ahụ.

Ọ ga-kwuru nwekwara na-arụsi ọrụ ike akụrụngwa nke gị n'ụlọnga reversibly ewee albumin. N'ihi obere ọdịnaya nke ikpeazụ na interstitial ọmụmụ, ịta nke ọgwụ na ya a obere elu karịa na ọbara.

Na ihe okwu ọgwụ na-ewepụtara a ndidi? Ihe o kwuru ntuziaka maka ojiji? "Lorakson» onye mejupụtara e tụlere n'elu, a na-egosipụta n'ihi na 8 awa (tinyere bile na mmamịrị). Ọ kwesịkwara kwuru na n'okpuru nduzi nke nsia na osisi nke na-arụsi ọrụ mmewere nke ngwá ọrụ a na-agbanwe na-adịghị ejekwa ozi metabolite.

Na ụmụ a mụrụ ọhụrụ, ọkara ndụ a na-ewere ọgwụ nke 8 ụbọchị, na ndị agadi (karịrị afọ 70), na oge a bụ 2 ugboro ọzọ.

The kinetics ọgwụ pụrụ iche ikpe

Mgbe malfunctions gbasara akụrụ usoro na na pathologies nke imeju na okenye ụmụ mmadụ ndị pharmacokinetics nke ceftriaxone bụ fọrọ agbanweghi agbanwe, a ọkara ndụ oge na-lengthened adịghị oké mkpa.

Mgbe akụrụ ọrụ na-mie budata, mkpochapu nke ọgwụ na-ewe ebe tumadi na bile, ma ọ bụrụ na mebiri emebi imeju, na ceftriaxone ewepụtara tumadi via na akụrụ ya.

Na ụmụ ọhụrụ na-amụ ije na-mbufụt nke meninges a agwọ ọrịa nwere ike iru n'ime ndị cerebrospinal ọmụmụ. Na okenye na meningitis mgbe 5-25 awa mgbe nlekọta a onunu ogwu nke ceftriaxone 50 mg / n'arọ ahu arọ ọtụtụ ugboro ya ịta karịa ndị MAỊ, nke a chọrọ maka suppression nke bacteria nke na-akpata ọrịa.

na-agba akaebe

Mgbe m kwesịrị ime na ọgwụ injection "Lorakson 500"? Ntuziaka maka ojiji (injections kwesịrị inye naanị ahụmahụ dọkịta) na-ekwu na ọgwụ na-iji na-emeso na-efe efe na mkpali oria mere site bacteria chebaara ọgwụ. N'ihi ya, ọ na-arụsi ọrụ eji na:

• meningitis;
• na-efe efe nke elu akụkụ okuku ume na tract;
• sepsis;
• urinary tract-efe efe na akụrụ;
• efe efe na omumu usoro (gụnyere gonorrhea);
• abdominal na-efe efe (gụnyere mkpali oria nke eriri afọ, peritonitis, biliary tract ọrịa);
• na-efe efe nke anụ;
• na-efe efe nke akụkụ okuku ume tract (gụnyere oyi baa);
• na-efe efe, na nkwonkwo na ọkpụkpụ anụ ahụ;
• na-efe efe na ndị mmadụ na zie ọgụ.

Ọzọkwa, n'aka ike ga-atụle gosiri maka mgbochi nke na-efe efe ọnya na postoperative oge.

Bans nhọpụta

È nwere contraindications hotara na mbụ ọgwụ ọjọọ? Ihe o kwuru ịdọkapụta ntuziaka maka ojiji? "Lorakson" na-egosi nke e depụtara n'elu, na-ekwesịghị kenyere ndị na-esonụ mgbe:

• ndidi na hypersensitivity ka penicillins na cephalosporins;
• ke akpa trimester nke afọ ime.

Na a ịkpachara anya na nke a ọgwụ na-atụ aro ka ndị mmadụ na ọrịa imeju, afọ na enteritis. Ọzọkwa, ịkpachara anya ga-gosipụtara mgbe NUC, hyperbilirubinemia na ụmụ ọhụrụ na abụọ ikpeazụ trimesters nke afọ ime, na akaghi aka ụmụ ọhụrụ na ara.

Ntuziaka maka ojiji

"Lorakson" ndinọ ọrịa intravenously ma ọ bụ intramuscularly. The nkezi, kwa ụbọchị onunu ogwu nke ọgwụ ndị okenye na ụmụaka si afọ 12 bụ 1-2 g ugboro kwa ụbọchị (kwa awa 24).

Na oké ikpe, nakwa dị ka na-efe efe na-kpatara pathogens moderately mwute, a kwa ụbọchị dose nke a gị n'ụlọnga nwere ike ụba na 4 g

Newly mụrụ ụmụ na-adọ ọgwụ 1 oge kwa ụbọchị na-atụ aro ndị na-esonụ onunu ogwu: 20-50 mg / n'arọ (ruo izu 2 nke afọ).

Baby-amụ ije na ụmụ ruo afọ 12, ndị dose kwa ụbọchị kwesịrị 20-75 mg / n'arọ. Eto eto na ahu arọ nke 50 n'arọ agwọ ọrịa Dosages ndinọ okenye.

Na oge nke ọgwụgwọ site nke a pụtara na-adabere na ọrịa.

Okwu na-akwadebe ihe ngwọta

Olee otú iji kwadebe a ọgwụ ngwọta? Gịnị ụgwọ a na-ekwu, ntụziaka ntuziaka? "Lorakson" ntọhapụ ụdị nke a n'ihu n'elu, n'ihi na intramuscular injection ga-diluted (1 g) na 3.5 ml nke 1% - ngwọta nke lidocaine, na ibà nnọọ n'ime ndị gluteal muscle.

Iji kwadebe a Nwa maka igba ogwu n'akwara ogwu ogbugba, 1 g nke ntụ ntụ ga-diluted na 10 ml distilled mmiri (akpali mmasị). The ngwọta ikpeazụ a ga-ji nwayọọ nwayọọ na ẹkenam n'ime a akwara (maka 4 nkeji).

Maka igba ogwu n'akwara infusion nke 2 g nke ọgwụ chọrọ igbari na 40 ml nke a ngwọta (e.g., sodium chloride, dextrose ma ọ bụ fructose), free si calcium. Nke a infusion ga-rụrụ dịkarịa ala ọkara otu awa.

Ebibi site-agwa

Ò iwe ọgwụ ngwọta "Lorakson"? Ntuziaka maka ojiji (injections ga-eme naanị na a na ụlọ ọgwụ) rụrụ ụka na na onodu nke-eji nke a ọgwụ onye ọrịa nwere ike ịzụlite:

• ọgbụgbọ, leukopenia na vomiting, granulocytopenia, afọ ọsịsa, hypocoagulation, afọ ntachi, hemolytic anaemia, flatulence, lymphopenia;
• abdominal mgbu, phlebitis, uto nsogbu, ihe mgbu, tinyere akwara, stomatitis, urticaria, glossitis, neutropenia;
• pseudomembranous enterocolitis, infiltration na ịdị nro na saịtị nke intramuscular ochichi, mkpọchị imeju ọrụ;
• mkpọchị gbasara akụrụ ọrụ, goiter, thrombocytosis, glycosuria, thrombocytopenia, oliguria, ọkụ ọkụ, azotemia, bronchospasm;
• abawanye nke urea na ọbara, eosinophilia, hypercreatininemia, polymorphic erythema, cylinduria, epistaxis, hematuria, superinfection, anuria;
• fever, ọbara ọrịa, fever, angioedema, pruritus, dizziness, anaphylactic ujo, candidiasis, isi ọwụwa.

Imekọ ihe ọnụ na ikpe nke ovadozu

Ovadozu nke ego na-egosipụta dizziness, isi ọwụwa, paresthesia, ụfụ, encephalopathy na amaghị onwe ya. Iji kpochapụ ndị a phenomena ide symptomatic ọgwụgwọ, ma na-akwado ndị dị mkpa ọrụ nke ahu.

Imekotaotuugbo ọgwụgwọ na ceftriaxone na aminoglycosides enwekwu ha antibacterial ọrụ. Iji gbochie na-egbu egbu na mmetụta nke ndị a elekọta mmadụ na-ndinọ n'oge dị iche iche na iche iche ebe.

-Ejikarị "Loraksona" Platelet aggregation inhibitors na NSAIDs e a elu n'ihe ize ndụ nke ọbara ọgbụgba.

Mgbe ị na-enweta a "loop" diuretics, e nwere oké ihe ize ndụ nke nephrotoxicity.

E lee ya anya ọgwụ ekwekọghịkwa ethanol, dị ka a na Nchikota na-akpata oké ọgbụgbọ, apịajighị apịaji na epigastric region, vomiting, flushing, mbelata nke ọbara mgbali na tachycardia.

Ọ na-machibidoro pịnye ke otu ntụtụ ceftriaxone na ndị ọzọ ọgwụ nje.

Yiri ọgwụ ọjọọ na nzaghachi on ọgwụ

Ugbu a na ị maara ihe a "Lorakson". Ntuziaka maka ojiji, pụtara analogs na-atụle n'isiokwu a.

Gịnị nwere ike dochie ọgwụ? N'ihi yiri ọgwụ ọjọọ ọkachamara tụlee: "Ceftriaxone-Promed" "Ceftriaxone-Elf," "Tsefogram", "Tsefson" "Ceftriaxone-Protekh" "Ceftriaxone-Dzhodas", "Tseftriabol", "Tsefatrin".

Dị ka Ibọrọ nke ọrịa, ihe ka ọtụtụ na-emekọ na-esi n'aka ha iji na-emeso elu akụkụ okuku ume na-efe efe na akụkụ okuku ume tract-efe efe. Inyocha ihe ha ozi, anyị nwere ike ikwubi ya ngwa ngwa edinam na elu arụmọrụ. Ọ kwesịkwara kwuru na mgbe eji a ọgwụ na ụfọdụ ọrịa e nwere obere mmetụta ndị na-achọ discontinuation nke ọgwụ.